IFP Advisors’s Cytosorbents Corp CTSO Stock Holding History

IFP Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-84	Closed	-$20K	–	3581
2022 Q4	$20K	Buy	84 +11	+15%	+$326	﹤0.01%	2871
2022 Q3	$17K	Hold	73	–	–	﹤0.01%	3227
2022 Q2	$17K	Hold	73	–	–	﹤0.01%	2983
2022 Q1	$17K	Buy	+73	New	+$5.23K	﹤0.01%	2983
2021 Q1	–	Sell	-98	Closed	-$18.7K	–	3041
2020 Q4	$16K	Hold	98	–	–	﹤0.01%	1864
2020 Q3	$16K	Buy	+98	New	+$17.7K	﹤0.01%	1728
2018 Q4	–	Sell	-22	Closed	-$6K	–	3582
2018 Q3	$6K	Buy	+22	New	+$5.52K	﹤0.01%	3114
2017 Q4	–	Sell	-280	Closed	-$35K	–	3852
2017 Q3	$35K	Hold	280	–	–	﹤0.01%	2221
2017 Q2	$24K	Hold	280	–	–	﹤0.01%	2462
2017 Q1	$25K	Hold	280	–	–	﹤0.01%	2349
2016 Q4	$31K	Hold	280	–	–	﹤0.01%	2171
2016 Q3	$36K	Hold	280	–	–	﹤0.01%	2010
2016 Q2	$25K	Buy	+280	New	+$24.4K	﹤0.01%	2192
2016 Q1	–	Sell	-280	Closed	-$31K	–	2569
2015 Q4	$31K	Buy	+280	New	+$38.1K	﹤0.01%	1887

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

IFP Advisors's CTSO Position: Q1 2023 in Review

IFP Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2023, closing a stake of 84 shares — an estimated $20K sold.

IFP Advisors first reported a position in CTSO in Q4 2015 and held it in 14 quarters. The position peaked at $36K in Q3 2016. 58 funds tracked by Wall St. Rank hold CTSO as of Q1 2023.

IFP Advisors reported no remaining Cytosorbents Corp position as of Q1 2023 after selling out during the quarter.
IFP Advisors sold 84 Cytosorbents Corp shares in Q1 2023, an estimated $20K.
IFP Advisors first reported a position in Cytosorbents Corp in Q4 2015 and held it in 14 quarters.
IFP Advisors's Cytosorbents Corp position peaked at $36K in Q3 2016.
58 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.